Physician profile
Steven C Humphreys
NPI 1144225798
$198,795.99
in general payments reported to CMS, 2019-2025
12 companies · $35K in 2025
The $35K reported for 2025 was more than what 84% of Orthopaedic Surgery of The Spine providers received nationally (typical 2025 total: $2,116).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $19K · 2020: $23K · 2021: $26K · 2022: $932 · 2023: $50K · 2024: $45K · 2025: $35K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Royalty Or License: $118K · Travel and Lodging: $9,761 · Food and Beverage: $1,929.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Royalty Or License | $118,110.00 |
| Travel and Lodging | $9,760.90 |
| Food and Beverage | $1,928.59 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Spineart Sa | $118,110.00 | 2023-2025 | Cure Acp - Anterior Cervical Plate, Cure Acpv2 - Anterior Cervical Plate, Opel C - Anterior Cervical Plate |
| Medical Investment Advisors LLC | $65,815.49 | 2019-2021 | |
| Stryker Corporation | $4,133.52 | 2019-2024 | Everest Spinal System, N/A, Prolift |
| Globus Medical, INC. | $3,911.74 | 2024 | Excelsiusgps Robotic Navigation System |
| Medtronic, INC. | $2,839.59 | 2021-2025 | Mazor X System, Affera Mapping System |
| Aesculap Implant Systems, LLC | $1,371.78 | 2023 | Activl |
| Spineart USA INC | $1,267.84 | 2021-2024 | |
| Si-Bone, INC. | $850.70 | 2019-2023 | |
| Abbott Laboratories | $199.27 | 2019-2023 | Proclaim |
| Osteoremedies, LLC | $141.03 | 2023 | Osteoboost Select 10cc |
| Medtronic USA, INC. | $82.82 | 2020 | |
| Depuy Synthes Sales INC. | $72.21 | 2024 | X-Pac |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Steven Humphreys listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.